Pharma major Dr Reddy’s Laboratories Ltd has launched Aripiprazole tablets, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the US. The used to treat certain mental/mood disorders. The Abilify brand and generic tablets had US sales of approximately $3.1 billion for the most recent 12 months ended August 2016, according to IMS Health.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.